Role of immunohistochemistry in differentiating epithelial mesothelioma from adenocarcinoma. Review and update.
University of Texas M. D. Anderson Cancer Center, Houston, USA.
N G
NG
Ordóñez
D000230:Adenocarcinoma / Q000175:diagnosis* / Q000378:metabolism / Q000556:secondary; D015703:Antigens, CD / Q000378:metabolism; D000951:Antigens, Neoplasm / Q000378:metabolism; D014408:Biomarkers, Tumor / Q000378:metabolism; D015820:Cadherins / Q000378:metabolism; D002135:Calcium-Binding Proteins / Q000378:metabolism; D003598:Cytoskeletal Proteins / Q000378:metabolism; D003937:Diagnosis, Differential; D004847:Epithelial Cells / Q000378:metabolism / Q000473:pathology*; D005404:Fixatives; D005557:Formaldehyde; D006652:Histological Techniques; D006801:Humans; D007124:Immunoenzyme Techniques; D008562:Membrane Glycoproteins / Q000378:metabolism; D008654:Mesothelioma / Q000175:diagnosis* / Q000378:metabolism; D010997:Pleural Neoplasms / Q000175:diagnosis* / Q000378:metabolism / Q000556:secondary
D015703:Antigens, CD; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D015820:Cadherins; D002135:Calcium-Binding Proteins; D003598:Cytoskeletal Proteins; D005404:Fixatives; D008562:Membrane Glycoproteins; D005557:Formaldehyde